JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB17147

Anti-CD8 alpha antibody [C8/144B]

Anti-CD8 alpha 항체 [C8/144B]

5

(9 리뷰들)

|

(138 제품이 사용된 논문 )

Anti-CD8 alpha antibody [C8/144B] (ab17147) is a mouse monoclonal antibody detecting CD8 alpha in Flow Cytometry, IHC-P. Suitable for Human.

- Over 100 publications
- Trusted since 2005
4 이미지
Flow Cytometry - Anti-CD8 alpha antibody [C8/144B] (AB17147)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-CD8 alpha antibody [C8/144B] (AB17147)

Human peripheral blood lymphocytes stained with ab17147 (red line). Human whole blood was processed using a modified protocol based on Chow et al, 2005 (PMID : 16080188). In brief, human whole blood was fixed in 4% formaldehyde (methanol-free) for 10 min at 22°C. Red blood cells were then lyzed by the addition of Triton X-100 (final concentration - 0.1%) for 15 min at 37°C. For experimentation, cells were treated with 50% methanol (-20°C) for 15 min at 4°C. Cells were then incubated with the antibody (ab17147, 1/100 dilution) for 30 min at 4°C. The secondary antibody used was Alexa Fluor® 488 goat anti-mouse IgG (H&L) (ab150113) at 1/2000 dilution for 30 min at 4°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >30,000 total events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. Gating strategy - peripheral blood lymphocytes.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [C8/144B] (AB17147)
  • IHC-P

AbReview60777****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [C8/144B] (AB17147)

Paraffin embedded human spleen tissue stained for CD8 alpha using ab17147 at 1/50 dilution in immunohistochemical analysis. Antigen retrieval step with Tris/EDTA pH 9.0.

This image is courtesy of an anonymous Abreview

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [C8/144B] (AB17147)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [C8/144B] (AB17147)

Paraffin embedded human tonsil tissue stained for CD8 T-Cell using ab17147 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [C8/144B] (AB17147)
  • IHC-P

PubMed

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [C8/144B] (AB17147)

Analysis of tumor-infiltrating lymphocytes. Immunohistochemical analysis of CD8 and CD4 (Original magnification, ×20). Typical examples of each staining are shown in both groups. Statistical analysis of each staining is shown. The number of CD8 (+) lymphocytes tends to be higher in the CS (+) group than in the CS (−) group, but the difference is not statistically significant (p = 0.052). The number of CD4 (+) lymphocytes shows no significant difference between the two groups (p = 0.28). Data represent the mean ± standard error of mean (CD4 and CD8, student's t-test).

Image from Sato M et al., J Clin Med., 8, 695. Fig 3.; doi: 10.3390/jcm8050695. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/.

주요 정보

Host species

Mouse

Clonality

Monoclonal

Clone number

C8/144B

Isotype

IgG1

Light chain 타입

kappa

Carrier free

No

Reacts with

Human

Applications

Flow Cyt, IHC-P

applications

Immunogen

Synthetic Peptide within Human CD8A. The exact immunogen used to generate this antibody is proprietary information.

P01732

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/100", "FlowCyt-species-notes": "<p><a href='/ko/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>" } } }

제품 세부 정보

Product Specifications

Anti-CD8 alpha antibody [C8/144B] (ab17147) is a mouse monoclonal antibody and is validated for use in Flow Cyt, IHC-P in human samples.
Anti-CD8 alpha antibody [C8/144B] (ab17147) specifically detects CD8 alpha (UniProt ID: P01732; Molecular weight: 24kDa) and is sold in 500 µL selling sizes.

Quality and Validation

Abcam's high quality validation processes ensure Anti-CD8 alpha antibody [C8/144B] (ab17147) has high sensitivity and specificity.
Anti-CD8 alpha antibody [C8/144B] (ab17147) has been cited over 103 times in peer reviewed journals and is trusted by the scientific community.
Anti-CD8 alpha antibody [C8/144B] (ab17147) has 9 independent reviews from customers.

Target Information

CD8 alpha is a transmembrane glycoprotein acting as a co-receptor for the T-cell receptor (TCR), predominantly present on cytotoxic T cells. It is vital for T cell signaling and cytotoxic function by binding to MHC class I molecules, supporting the immune response against infected or cancerous cells. CD8 alpha is linked to various diseases, especially those related to immune system dysfunction

특성 및 보관 정보

제형
Liquid
Purity
IgG fraction
보관 버퍼
pH: 7.3 - 7.5 Preservative: 0.05% Sodium azide Constituents: Tissue culture supernatant, 1% BSA
배송 시 보관 조건
Blue Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

CD8 alpha also known as CD8A or CD8 protein is a glycoprotein subunit expressed on the surface of cytotoxic T lymphocytes. It has a mass of approximately 32 kDa. Found on the surface cell membrane CD8 alpha functions primarily in the immune response specifically in the recognition of antigens bound to major histocompatibility complex (MHC) class I molecules. Often scientists use CD8 antibodies for detection and CD8 IHC or immunohistochemistry for localization studies.
Biological function summary

The CD8 alpha protein plays a critical role in T-cell mediated immune responses. It forms a heterodimer with the CD8 beta chain creating the CD8 alpha-beta complex that strengthens T-cell interaction with antigen-presenting cells. CD8 alpha also helps in signaling processes that activate T cells equipping them to destroy infected or malignant cells. Researchers often study CD8 alpha peptides to understand its interactions better.

Pathways

CD8 alpha is integral to the T-cell receptor signaling pathway and the cytotoxic T lymphocyte (CTL) pathway. The T-cell receptor complex which includes the CD8 molecule transmits signals that are important for T-cell activation and function. CD8 interacts with key proteins such as the T-cell receptor (TCR) and MHC class I molecules facilitating targeted responses against pathogens. These pathways highlight CD8 alpha’s role in adaptive immunity.

CD8 alpha is most prominently associated with viral infections and cancer. Conditions like HIV and some forms of leukemia show altered CD8 function highlighting the protein's role in immune surveillance. In HIV infection for instance CD8 T cells reduce in number impairing the immune response. CD8 alpha’s connection to the immune system places it alongside other immune proteins such as CD4 and MHC molecules in the context of immune dysfunction.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

The protein expressed by the gene CD8A is an integral membrane glycoprotein crucial for immune responses, operating mainly in T-cells as a coreceptor for MHC class I molecule : peptide complexes. These peptides originate from cytosolic proteins, unlike class II peptides, which are from extracellular proteins. CD8A interacts with the T-cell receptor (TCR) and MHC class I proteins on antigen-presenting cells, recruiting the Src kinase LCK to the TCR-CD3 complex. LCK phosphorylates substrates, triggering signaling pathways that lead to the production of lymphokines, enhanced motility, adhesion, and activation of cytotoxic T-lymphocytes (CTLs), thereby aiding in the recognition and elimination of infected or tumor cells. Additionally, in natural killer (NK) cells, CD8A homodimers on the cell surface provide a survival mechanism for conjugating with and lysing multiple target cells. CD8A homodimers also facilitate the survival and differentiation of activated lymphocytes into memory CD8 T-cells. This supplementary information is collated from multiple sources and compiled automatically.
See full target information CD8A

대체 명칭 보기

CD8a, MAL, CD8A, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2

제품이 사용된 논문 (138)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Cancer reports (Hoboken, N.J.) 8:e70345 PubMed41026775

2025

Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Takahiro Iwamoto,Kazuhiro Ogi,Takafumi Nakagaki,Takashi Sasaya,Sho Miyamoto,Koyo Nishiyama,Kenta Sasaki,Shintaro Sugita,Yasushi Sasaki,Akihiro Miyazaki

Journal of nanobiotechnology 23:413 PubMed40462160

2025

Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8 + TILs function and recruiting B cells in cervical cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Lili Jiang,Tong Wu,Xinyu Qu,Shuqi Li,Qi'an Jiang,Tingting Ren,Jiali Liang,Yan Ding,Keqin Hua,Zhongmin Tang,Junjun Qiu

Molecular therapy. Oncology 33:200986 PubMed40458686

2025

Epstein-Barr virus mRNA vaccine synergizes with NK cells to enhance nasopharyngeal carcinoma eradication in humanized mice.

Applications

Unspecified application

Species

Unspecified reactive species

Kun Huang,Xiao-Jun Lin,Jing-Chu Hu,Ting-Ying Xia,Feng-Ping Xu,Jian-Dong Huang,Nan Zhou

Cancer immunology, immunotherapy : CII 74:215 PubMed40411616

2025

LAG3 as a marker of immune activation in esophageal squamous carcinoma treated with concurrent chemoradiotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Yuxuan Zhang,Zijing Zhou,Yuanyuan Rui,Fanhao Kong,Zhoubo Guo,Gang Zhao,Jun Wang,Jiacheng Li,Fangdong Zhao,Hui Huang,Fang Fang,Jiarui Zhang,Tian Zhang,Wencheng Zhang,Ping Wang,Xi Chen,Peng Zhen,Qingsong Pang

NPJ precision oncology 9:37 PubMed39910169

2025

Deep visual proteomics reveals DNA replication stress as a hallmark of signet ring cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Sonja Kabatnik,Xiang Zheng,Georgios Pappas,Sophia Steigerwald,Matthew P Padula,Matthias Mann

Anticancer research 45:639-650 PubMed39890197

2025

Efficacy of Second-line Nivolumab Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Applications

Unspecified application

Species

Unspecified reactive species

Gaku Yamamichi,Taigo Kato,Akihiro Yoshimura,Masaru Tani,Yuki Horibe,Yutong Liu,Nesrine Sassi,Yohei Okuda,Toshiki Oka,Toshihiro Uemura,Akinaru Yamamoto,Y U Ishizuya,Takuji Hayashi,Yoshiyuki Yamamoto,Koji Hatano,Atsunari Kawashima,Tetsuya Takao,Kensaku Nishimura,Shingo Takada,Masao Tsujihata,Norio Nonomura

Molecular cancer 23:285 PubMed39736629

2024

The miR-23a/27a/24 - 2 cluster drives immune evasion and resistance to PD-1/PD-L1 blockade in non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Luo,Bin Hu,Xiang-Rong Gu,Jing Chen,Xiao-Qing Fan,Wei Zhang,Ren-Tao Wang,Xian-Dong He,Wei Guo,Nan Dai,Dan Jian,Qing Li,Cheng-Xiong Xu,Hua Jin

BMC veterinary research 20:560 PubMed39658799

2024

Successful diagnosis and treatment of canine polymyositis: utilizing MRI and immunohistochemistry for accurate detection.

Applications

Unspecified application

Species

Unspecified reactive species

Jungwoo Han,KeunHwan Jang,Seung-Bum Cho,SuYeon Kim,Songju Oh,Ha-Jung Kim

Nature cardiovascular research 3:1482-1502 PubMed39613875

2024

Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factors.

Applications

Unspecified application

Species

Unspecified reactive species

José Gabriel Barcia Durán,Dayasagar Das,Michael Gildea,Letizia Amadori,Morgane Gourvest,Ravneet Kaur,Natalia Eberhardt,Panagiotis Smyrnis,Burak Cilhoroz,Swathy Sajja,Karishma Rahman,Dawn M Fernandez,Peter Faries,Navneet Narula,Rami Vanguri,Ira J Goldberg,Edward A Fisher,Jeffrey S Berger,Kathryn J Moore,Chiara Giannarelli

Biomarker research 12:147 PubMed39587633

2024

GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Gaku Yamamichi,Taigo Kato,Noriaki Arakawa,Yoko Ino,Takeshi Ujike,Kosuke Nakano,Yoko Koh,Yuichi Motoyama,Hidetatsu Outani,Shohei Myoba,Yu Ishizuya,Yoshiyuki Yamamoto,Koji Hatano,Atsunari Kawashima,Shinichiro Fukuhara,Hiroji Uemura,Seiji Okada,Eiichi Morii,Norio Nonomura,Motohide Uemura
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com